Maternal serologic screening for toxoplasmosis

Journal of Midwifery and Women's Health

Volumn 48, Issue 5, 2003, Pages 308-316

  Pinard, Jennifer A ^b   Leslie, Nan S ^a   Irvine, Pamela J ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

^b NONE

Author keywords

Serologic screening; T. gondii; Toxoplasmosis

Indexed keywords

FOLIC ACID; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

ARTICLE; BONE MARROW SUPPRESSION; CAT; CORRELATION ANALYSIS; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIOLOGICAL DATA; FECES; FETUS DISEASE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INCIDENCE; MATERNAL SERUM; MEAT; MEDICAL ETHICS; PARASITE; PLACENTAL TRANSFER; PREGNANCY; PREVALENCE; PROTOZOON; SCREENING TEST; SEROCONVERSION; SEROLOGY; SOIL POLLUTION; TERATOGENICITY; TOXOPLASMOSIS; UNITED STATES; WATER CONTAMINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; CATS; DISEASE VECTORS; FEMALE; FOOD PARASITOLOGY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MASS SCREENING; MEAT; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; PREVALENCE; SEROLOGIC TESTS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; UNITED STATES;

EID: 0141725345     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-9523(03)00279-4     Document Type: Article

References (31)

1. Guerina N. Hsu H. Meissner C. Maguire J. Lynfield R. Stechenberg B. et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection N Engl J Med 33026 1994 1858-1863
2. American College of Obstetrician Gynecologists Perinatal viral parasitic infections. ACOG Policy Bulletin 20 2000 American College of Obstetricians and GynecologistsWashington (DC)
3. Lopez, A, Dietz VJ, Wilson F, Navin TR, Jones JL. Preventing congenital toxoplasmosis. In Centers for Disease Control and Prevention. CDC recommendations regarding selected conditions affecting women's health. MMWR [Internet] 2000;49(RQ-2RR-2):57-74. [cited January 7, 2003] Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4902a5.htm
4. Foulon W. Naessens A. Derde M. Evaluation of the possibilities for preventing congenital toxoplasmosis Am J Perinatol 111 1994 57-62
5. Mittendorf R. Pryde P. Herschel M. Willims M.A. Is routine antenatal toxoplasmosis screening justified in the United States? Statistical considerations in the application of medical screening tests Clin Obstet Gynecol 421 1999 163-175
6. Bader T.J. Macones G.A. Asch D.A. Prenatal screening for toxoplasmosis Obstet Gynecol 903 1997 457-464
7. Hunter K. Stagno S. Capps E. Smith R. Prenatal screening of pregnant women of infections caused by cytomegalovirus, Epstein-Barr virus, herpesvirus, rubella, and Toxoplasma gondii Am J Obstet Gynecol 1453 1983 269-273
8. Frenkel J.K. Dubey J.P. Toxoplasmosis and its prevention in cats and man J Infect Dis 1266 1972 664-673
9. Jones J. Lopez A. Wilson M. Schulkin J. Gibbs R. Congenital toxoplasmosis : A review Obstet Gynecol Surv 565 2001 296-305
10. Greene C. Pet ownership for immunocompromised people. In Bonagura. J.D. Kirk R.W. (Eds.), Kirk's Current Veterinary Therapy. XII. Small Animal Practice 1995 275 Saunders Philadelphia
11. Division of Parasitic Diseases. Toxoplasmosis gondii life cycle. In Identification and Diagnosis of Parasites of Public Health Concern. Parasite Image Library, Division of Parasitic Diseases. Atlanta (GA): Centers for Disease Control and Prevention, 2001. [cited April 12, 2003] Available from: http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm
12. Gilstrap L. Faro S.Infections in pregnancy, 2nd ed 1997 Wiley-Liss New York
13. Piper J. Wen T. Perinatal cytomegalovirus and toxoplasmosis : Challenges of antepartum therapy Clin Obstet Gynecol 421 1999 81-94
14. Lappin M. CVT update : Feline toxoplasmosis. In Bonagura J.D. Kirk R.W. (Eds.), Kirk's Current Veterinary Therapy. XII Small Animal Practice 1995 309-314 Saunders Philadelphia
15. Mead P.S. Slustker L. Deitz V. McCaig L. Bresee J.S. Shapiro C. et al. Food-related illness and death in the United States Emerg Infect Dis 55 1999 607-625
16. Gilbert R, Peckham CS. Congenital toxoplasmosis in the United Kingdom: To screen or not to screen. J Med Screen 2002;9:135-41
17. Dunn D. Wallon M. Peyron F. Pertersen E. Peckham C. Gilbert R. Mother-to-child transmission of toxoplasmosis : Risk estimates for clinical counseling Lancet 353 1999 1829-1833
18. Peyron F, Wallon M, Liou C, Garner P. Treatments for toxoplasmosis in pregnancy (Cochrane Review). In The Cochrane Library 2003;1: Oxford: Update Software
19. Wilson C. Remington J. What can be done to prevent congenital toxoplasmosis? Am J Obstet Gynecol 1384 1980 357-363
20. Centers for Disease Control and Prevention. Parasitic disease information. Fact sheet: Toxoplasmosis. 2003. [cited April 12, 2003] Available from: http://www.cdc.gov/ncidod/dpd/parasites/toxoplasmosis/ factsht⊤xoplasmosis.htm
21. American Academy of Family Physicians. Toxoplasmosis in pregnancy. 2001. [cited March 20, 2003] Available from: http://www.familydoctor.org/handouts/180.html
22. Montoya J. Laboratory diagnosis of toxoplasmosis gondii infection and toxoplasmosis J Infect Dis 185suppl 1 2002 S73-82
23. Wilson M. Remington J. Clavet C. Varney G. Pres C. War D. FDA Toxoplasmosis Ad Hoc Working Group Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii J Clin Microbiol 3512 1997 3112-3115
24. Sever J. Toxoplasmosis in pregnancy. In Mead P. Hager D. (Eds.), Infection Protocols for Obstetrics and Gynecology 1992 131-133 Medical Economics Publishing Montvale (NJ)
25. Food and Drug Administration. FDA public health advisory: Limitations of toxoplasmosis IgM commercial test kits. 1997. [cited March 25, 2003] Available from: www.fda.gov/cdrh/toxopha.htm
26. Liesenfeld O. Press C. Montoya J. Gill R. Isaac-Renton J. Hedman K. et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing : The Platelia Toxo IgM Test J Clin Microbiol 351 1997 174-178
27. Hohlfeld P. Daffos F. Costa J. Thulliez P. Forestire F. Viduaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid N Engl J Med 33111 1994 695-699
28. Romand S. Wallon M. Franck J. Thulliez P. Peyron F. Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis Obstet Gynecol 972 2001 296-300
29. Grover C. Thulliez P. Remington J. Boothroyd J. Rapid prenatal diagnosis of congenital toxoplasma infection by using polymer-ase chain reaction and amniotic fluid J Clin Microbiol 2810 1990 2297-2301
30. Sever J. Toxoplasmosis in pregnancy Contemp Obstet Gynecol 43 1998 21-24
31. Daffos F. Forestier F. Capella-Pavlovsky M. Thulliez P. Aufrant C. Valenti D. et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis N Engl J Med 3185 1988 271-275